300086.SZ
Honz Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.42
−3.02%Year over year
Reported trailing growth
- Revenue
- -5.6%
- EBITDA
- —
- EBIT
- -43.4%
- EPS
- -29.0%
- Free cash flow
- +5262.7%
- Operating cash flow
- -59.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -30.3%
- EBIT
- -20.0%
- Net income
- -6.8%
- EPS
- -5.9%
- Free cash flow
- +238.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026